Clinical trials for elderly patients — when experimental treatment is an option

Reviewed by a board-certified geriatric medicine specialist

Clinical trials give your parent access to treatments that aren't otherwise available, and modern protections make them far safer than most families assume. The NIH maintains over 400,000 studies on ClinicalTrials.gov, with growing numbers actively recruiting adults over 65. When standard treatment has stopped working, an experimental trial may offer a genuine path forward rather than a shot in the dark.

Modern Clinical Trials Offer Regulated Access to New Treatments With Strong Ethical Protections, and Older Adults Are Increasingly Eligible and Actively Recruited

Clinical trials have a reputation problem. When someone hears that a medication or treatment is "experimental," there's often fear. The word brings up images of dangerous medical testing and vulnerable people being exploited. Some of that history is real and documented. But modern clinical trials, particularly for older adults, are far more regulated and protective than the trials of decades past. Every trial in the United States must be reviewed by an Institutional Review Board (IRB) before it can begin, and the FDA oversees the entire process from design to completion.

The reason to understand clinical trials is simple: sometimes they offer your parent access to treatment that isn't otherwise available. If standard treatments aren't working, if your parent's condition is rare, if conventional medicine has run out of options, a clinical trial may offer something worth considering.

What is a clinical trial? It's a research study testing whether a new medication, treatment approach, or intervention is safe and effective. Trials happen in phases. Phase 1 tests safety in a small group. Phase 2 tests whether it works. Phase 3 compares it to standard treatment in a larger group. Phase 4 monitors it after approval. Older adults are often included in Phase 2, 3, and 4 trials but less often in Phase 1, where the risks are highest.

The ethics of modern trials are strict. Every trial is reviewed by an IRB or ethics committee before it starts. The committee ensures the study is designed to minimize harm, that participants will be fully informed, that they can withdraw at any time without penalty. Researchers are required to tell participants about known risks. Participants sign informed consent forms describing what's involved. The NIH requires that informed consent be written in plain language that participants can actually understand. None of this is foolproof, but the protections are real and enforceable.

Finding trials for your parent's condition involves some research. ClinicalTrials.gov, maintained by the NIH, lists thousands of active trials searchable by condition, location, age, and other factors. Your parent's doctor may know of relevant trials. Disease-specific organizations like the Alzheimer's Association, the American Cancer Society, and the American Heart Association maintain lists of trials seeking participants.

The question of whether your parent should participate deserves careful consideration. The standard treatment didn't work or isn't tolerated. The experimental treatment may work, or it may not. There could be unknown risks. But there's also potential benefit that wouldn't exist otherwise.

Before deciding, understand the trial specifics. What is the experimental treatment? What are the known risks based on earlier phases? What are the known benefits in other groups? How is this trial different from standard treatment? What does participation involve in terms of visits, tests, and time commitment? Will your parent be randomly assigned to treatment or control group, and if so, might they receive placebo instead of treatment? Can they withdraw from the trial?

Some trials give all participants the experimental treatment. Some use randomization, meaning your parent may get it or may get standard treatment. Some use a placebo control, meaning they may get a placebo while another group gets the experimental treatment. This is important to understand before committing.

The control group aspect troubles some families. If your parent is randomized to receive standard treatment or placebo while they'd otherwise get a potentially beneficial experimental treatment, is that ethical? The answer is that in genuine clinical trials, researchers do not yet know whether the experimental treatment is better. That's what the trial is designed to find out. If researchers already knew the experimental treatment was better, the trial would be unnecessary and the control group would be unethical. Data safety monitoring boards review results throughout the trial and will stop it early if the evidence becomes clear in either direction.

The time commitment matters. Some trials require frequent visits, lab work, and testing. Some require hospitalization. Some are less intensive. The NIH encourages trial sponsors to accommodate participants' needs, but the reality is that for someone with limited mobility or energy, frequent visits may be difficult. For someone already struggling with treatment burden, adding more appointments may be too much.

The side effects of experimental treatments are, by definition, not fully known. This is the biggest risk. Researchers know some possible risks based on animal studies or early trials in smaller groups. But unexpected effects can occur. Your parent could experience side effects that standard treatment wouldn't cause. This is why informed consent matters: your parent is accepting possible unknown risks for possible unknown benefits.

There are protections in place. If serious side effects appear, the trial can be stopped. If the experimental treatment is clearly better than standard treatment, the trial can be stopped early and everyone given the better option. If it's clearly worse, the same happens. Independent data safety monitoring boards watch for problems throughout.

Your parent's age sometimes disqualifies them from trials. The FDA has issued guidance encouraging trial sponsors to include older adults, noting that age-related exclusions should be justified by scientific evidence, not assumptions about frailty. Many trials now actively recruit older adults because understanding how treatments work in this population is essential. If your parent is excluded from a trial because of age alone, that's worth discussing with the researcher.

Being in a trial sometimes has advantages beyond the experimental treatment. Your parent gets close monitoring. They get frequent appointments with specialists. They get tests they might not otherwise get. They're part of a research team working toward answers. Some people find real meaning in contributing to scientific knowledge, even if the trial doesn't help them personally.

The risk of harm versus the potential benefit needs honest assessment. If your parent's condition is terminal and standard treatment isn't working, the risk calculation changes. An experimental treatment has less to lose because the status quo is already bad. If your parent's condition is stable but imperfect, the calculation may be different. Taking a risk to improve an okay situation requires different thinking than taking a risk to change a dire one.

Your parent's wishes matter most. Some people are excited about trying experimental treatment. They feel like they're part of something meaningful. Others are frightened by the word "experimental" and would never choose it. Some would consider it only if certain conditions are met. Understanding what your parent actually wants, not what you think they should want, is essential.

The paperwork is important. Read the informed consent carefully. Ask questions about anything that's unclear. Ask the researchers directly about risks and benefits. Ask whether your parent can withdraw at any time. Ask what happens if something goes wrong. Ask about costs: Medicare covers routine care costs for beneficiaries in qualifying clinical trials, and many trials cover the cost of the experimental treatment itself.

After your parent commits to a trial, ongoing communication with the research team matters. Report any symptoms or side effects. Attend all appointments. Let the researchers know if your parent's health changes. Communicate if your parent wants to withdraw. They have the right to leave at any time without it affecting their regular medical care.

Sometimes participating in a trial leads to the experimental treatment being approved. Your parent may be among the first people to access a genuinely helpful new medication. Sometimes the trial shows the treatment doesn't work. That's also valuable information. Sometimes trials provide answers that benefit others even if they don't help your parent directly.

Clinical trials aren't exploitation when they're done right. They're research that may benefit your parent while contributing to knowledge that helps others. But they require careful consideration, honest assessment of risks and benefits, and full information before deciding.

Frequently Asked Questions

Does my parent have to pay to be in a clinical trial?
Most clinical trials cover the cost of the experimental treatment and related tests. Medicare covers routine care costs for beneficiaries enrolled in qualifying clinical trials under the Clinical Trial Policy established in 2000. Your parent should ask the research team about all costs before enrolling, including travel, time off for appointments, and any tests not covered by the trial.

Can my parent leave a clinical trial if they change their mind?
Yes. The FDA and NIH require that all trial participants can withdraw at any time, for any reason, without penalty or loss of regular medical care. This right is spelled out in the informed consent document. If your parent wants to leave, they notify the research team, and their regular doctor continues their care.

How do I find clinical trials for my parent's specific condition?
Start at ClinicalTrials.gov, the NIH database of registered studies. You can search by condition, location, age, and trial phase. Your parent's specialist may also know of trials at their institution or nearby academic medical centers. Disease-specific organizations often maintain trial-matching services.

Are older adults treated fairly in clinical trials?
The FDA has been working to address historic underrepresentation of older adults in trials. In 2020, the FDA issued guidance urging that age-based exclusions be scientifically justified. Many trials now specifically recruit adults over 65 because medications often work differently in older bodies, and the data from younger populations doesn't always apply. Ask the research team about their experience with older participants.

What if the trial uses a placebo and my parent gets the sugar pill instead of the real treatment?
Not all trials use placebos. Many compare the experimental treatment to the current best available treatment, meaning all participants get active treatment. When placebos are used, it's because there is genuine uncertainty about whether the experimental treatment works. Data monitoring boards review results continuously and will stop a trial early if one group is doing significantly better or worse. Ask before enrolling whether the trial uses a placebo and what the odds of receiving it are.

My parent's doctor says there are no more treatment options. Should we look into clinical trials?
Yes. This is exactly the situation where clinical trials are most appropriate. When standard treatment has been exhausted, an experimental treatment offers a chance that didn't previously exist. Talk to your parent's specialist about whether any trials match their condition, check ClinicalTrials.gov, and contact the research teams directly to ask about eligibility.